Danaher (DHR)
(Delayed Data from NYSE)
$239.60 USD
-3.65 (-1.50%)
Updated Nov 12, 2024 04:00 PM ET
After-Market: $239.58 -0.02 (-0.01%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$239.60 USD
-3.65 (-1.50%)
Updated Nov 12, 2024 04:00 PM ET
After-Market: $239.58 -0.02 (-0.01%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Zacks News
The Zacks Analyst Blog Highlights Danaher, Comcast, Starbucks, The TJX Companies and Stryker
by Zacks Equity Research
Danaher, Comcast, Starbucks, The TJX Companies and Stryker are part of the Zacks top Analyst Blog.
Q3 Earnings Season Scorecard and Analyst Reports for Danaher, Comcast & Starbucks
by Sheraz Mian
Today's Research Daily features a real-time update on the Q3 earnings season and new research reports on Danaher (DHR), Comcast (CMCSA) and Starbucks (SBUX).
Danaher's (DHR) Q3 Earnings Beat, Up Y/Y on Higher Sales
by Zacks Equity Research
Danaher's (DHR) Q3 results benefit from higher revenues across all segments. Organic sales rise 10%, while acquisition//divestitures boost sales by 1.5%.
Danaher (DHR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 14.29% and 8.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Danaher (DHR) Ahead of Earnings?
by Zacks Equity Research
Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Danaher (DHR) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3M (MMM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
3M (MMM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danaher (DHR) Stock Moves -1.38%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $253.71, marking a -1.38% move from the previous day.
Will Cost Woes be a Spoiler for Danaher's (DHR) Q3 Earnings?
by Zacks Equity Research
High raw material costs and supply chain disruptions are likely to have hurt Danaher's (DHR) Q3 earnings. However, the top line is expected to have benefited from strong segmental performances.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $251.68 in the latest trading session, marking a -0.97% move from the prior day.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $282.29, marking a +1.16% move from the previous day.
Key Reasons to Retain Danaher (DHR) Stock in Your Portfolio
by Zacks Equity Research
Healthy bioprocessing and consumables business bode well for Danaher (DHR). The company's shareholder friendly policies add to its attractiveness.
Danaher (DHR) Stock Moves -0.98%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $262.66, marking a -0.98% move from the previous day.
The Zacks Analyst Blog Highlights Microsoft, Danaher, Raytheon Technologies, Stryker Corporation and Vale
by Zacks Equity Research
Microsoft, Danaher, Raytheon Technologies, Stryker Corporation and Vale are included in this Analyst Blog.
Top Stock Reports for Microsoft, Danaher & Raytheon Technologies
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Danaher Corporation (DHR) and Raytheon Technologies Corporation (RTX).
Danaher (DHR) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $278.94 in the latest trading session, marking a +0.68% move from the prior day.
Danaher (DHR) to Spin-Off Environmental Unit, Shares Pop
by Zacks Equity Research
The spin-off of the Environmental & Applied Solutions segment into a new public company should help Danaher (DHR) focus on its Life Sciences and Diagnostics segments.
Danaher (DHR) Stock Moves 1.06%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $293.51, marking a +1.06% move from the previous day.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $272.48 in the latest trading session, marking a +1.14% move from the prior day.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $276.69, moving -1.3% from the previous trading session.
Here's Why Investors Should Retain Danaher (DHR) Stock for Now
by Zacks Equity Research
Danaher (DHR) is benefiting from strength in its Life Sciences segment, acquisitions and shareholder-friendly actions despite supply-chain challenges and escalating costs.
The Zacks Analyst Blog Highlights Alphabet, Danaher, Wells Fargo, United Parcel Service and Equinor
by Zacks Equity Research
Alphabet, Danaher, Wells Fargo, United Parcel Service and Equinor are included in this Analyst Blog.
Top Research Reports for Alphabet, Danaher & Wells Fargo
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Danaher Corporation (DHR) and Wells Fargo & Company (WFC).
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
The Zacks Analyst Blog Highlights Broadcom, Oracle, Danaher, Deere and Northrop Grumman
by Zacks Equity Research
Broadcom, Oracle, Danaher, Deere and Northrop Grumman are included in this Analyst Blog.